Physician

Achini Perera Dingman, MD

According to 2025 Medicare claims, Achini Dingman, MD (NPI: 1174594758) practices rheumatology in the Boise City, ID market, with the plurality of this provider's patient population coming from Ada, ID. This provider's primary affiliated billing organization is TREASURE VALLEY RHEUMATOLOGY PLLC (NPI: 1295455475; TIN: 88-3448835) and primary practice location at 83642-2452. Dingman is affiliated with the MountainStar Care Partners ACO (ACO ID: A5181) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Dingman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 162 traditional Medicare patients, billed 27,691 HCPCS/CPT codes, and received $382,310 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,324 prescription claims across 210 beneficiaries totaling $170,724 in drug costs, led by Leflunomide (Leflunomide). Open Payments data shows 33 records totaling $431. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,023 to $382,310. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	18	24	$2,023
2017	125	310	$20,939
2018	148	375	$22,775
2019	150	341	$20,869
2020	138	380	$22,153
2021	165	421	$31,605
2022	171	425	$30,377
2023	144	12,653	$180,261
2024	162	27,691	$382,310

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	12	40	$1,199
2017	100	540	$105,153
2018	141	990	$247,700
2019	165	1,117	$451,936
2020	218	1,390	$773,295
2021	229	1,342	$984,700
2022	259	1,619	$1,527,232
2023	204	1,142	$603,256
2024	210	1,324	$170,724

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	44	44	$155
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	46	59	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	125	278	$84
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	131	303	$11
36415	Insertion of needle into vein for collection of blood sample	49	53	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Leflunomide	Leflunomide	85	5,852	$8,476
Methotrexate	Methotrexate Sodium	276	19,373	$6,933
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	166	11,947	$5,550
Mycophenolate Mofetil	Mycophenolate Mofetil	17	1,350	$3,596
Sulfasalazine	Sulfasalazine	77	4,155	$2,286

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	33	$431	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Achini Perera Dingman, MD?

Tedicare shows public-source Medicare data for Achini Perera Dingman, MD (NPI 1174594758), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Achini Perera Dingman, MD have ACO affiliation data?

Achini Perera Dingman, MD is shown with ACO affiliation data for MountainStar Care Partners ACO (MSSP, ACO ID A5181) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Achini Perera Dingman, MD?

Achini Perera Dingman, MD is linked to TREASURE VALLEY RHEUMATOLOGY PLLC (billing NPI 1295455475) in the available physician profile data.

Does Achini Perera Dingman, MD have Open Payments data?

Achini Perera Dingman, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.